ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.54
      0.08%
      US Tech 100
      18,558.00
      0.21%
      Dow Jones
      40,539.93
      -0.12%
      Brent Oil
      79.145
      -1.77%
      Bitcoin
      67,206.23
      -0.87%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kronos Bio Inc (KRON)

      7. Kronos Bio Inc (KRON) Financials

      Kronos Bio Inc

      Kronos Bio Inc (KRON)

      Kronos Strategy
      1.23
      -0.09
      (-6.82%)
      At close: July 29 4:00PM
      Delayed by 15 minutes
      1.2119
      -0.0181
      ( -1.47% )
      After Hours: 5:59PM
      Delayed by 15 minutes

      Kronos Bio Inc Financial Summary

      The current KRON market cap is 72.83M. The company's latest EPS is USD -1.8749 and P/E is -0.66.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.22M1.86M918k2.29M2.52M
      Operating Income -28.49M-32.17M-33.82M-27.34M-31.99M
      Net Income -26.24M-29.74M-31.37M-25.32M-29.96M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00006.29M
      Operating Income -16.82M-58.04M-151.4M-137.12M-121.83M
      Net Income -16.12M-88.44M-151.08M-133.2M-112.67M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 289.03M260.62M237.99M213.28M182.98M
      Total Liabilities 63.42M57.27M59.37M54.2M46.01M
      Total Equity 225.61M203.34M178.62M159.08M136.97M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 102.69M511.96M391.48M294.94M213.28M
      Total Liabilities 2.98M46.45M46.38M50.44M54.2M
      Total Equity -23.2M465.52M345.1M244.5M159.08M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.95M-30.97M-53.56M-78.58M-23.9M
      Investing -6.36M-981k34.81M66.37M5.77M
      Financing N/A 376k376k567k N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -15.08M-37.91M-117.92M-90.93M-78.58M
      Investing -67.58M-160.24M63.72M-32.22M66.37M
      Financing 105.01M415.61M4.46M851k567k

      Stats and Ratios

      Market Cap 72.83M
      Price to Earnings Ratio -0.66
      Price to Sales Ratio 11.85
      Price to Cash Ratio 1.16
      Price to Book Ratio 0.47
      Dividend Yield -

      Share Statistics

      Shares Outstanding 60.09M
      Average Volume (1 week) 106.62k
      Average Volume (1 Month) 197.97k
      52 Week Change -39.71%
      52 Week High 2.09
      52 Week Low 0.69
      Spread (Intraday) 0.18 (13.04%)

      Company Info

      Company Name Kronos Bio Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.kronosbio.com
      Industry pharmaceutical preparations (2834)